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Familial hemiplegic migraine is an episodic neurological disorder characterized by transient
sensory and motor symptoms and signs. Mutations of the ion pump α2-Na/K ATPase cause
familial hemiplegic migraine, but the mechanisms by which α2-Na/K ATPase mutations lead
to the migraine phenotype remain incompletely understood. Here, we show that mice in
which α2-Na/K ATPase is conditionally deleted in astrocytes display episodic paralysis.
Functional neuroimaging reveals that conditional α2-Na/K ATPase knockout triggers spon-
taneous cortical spreading depression events that are associated with EEG low voltage
activity events, which correlate with transient motor impairment in these mice. Tran-
scriptomic and metabolomic analyses show that α2-Na/K ATPase loss alters metabolic gene
expression with consequent serine and glycine elevation in the brain. A serine- and glycine-
free diet rescues the transient motor impairment in conditional α2-Na/K ATPase knockout
mice. Together, our findings define a metabolic mechanism regulated by astrocytic α2-Na/K
ATPase that triggers episodic motor paralysis in mice.
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Familial hemiplegic migraine is an episodic neurologicaldisorder that features transient sensory and motor aurasymptoms and signs. Typically associated with headache, the
transient neurological disturbances in familial hemiplegic
migraine may be sufficiently severe to manifest as hemiparesis or
ataxia1–4. Familial hemiplegic migraine episodes occur with
variable though characteristically low frequency1. Mutations in
three genes encoding ion channels, including the ion pump α2-
Na/K ATPase cause familial hemiplegic migraine5–8, but how
mutations of α2-Na/K ATPase lead to the migraine phenotype
remains incompletely understood.
The ion pump Na/K ATPase is expressed in most eukaryotic
cells. In addition to generating sodium and potassium ion gra-
dients across the plasma membrane, the Na/K ATPase harbors
signaling functions9–11. The α subunit of Na/K ATPase encodes
the primary catalytic machinery of the ion pump12–16. Among
four α isoforms, neurons predominately express α1 and α3,
whereas astrocytes predominately express α2 (refs. 17–19). Unlike
the α1 isoform, which is found uniformly within the plasma
membrane, the α2 isoform in astrocytes is particularly enriched
adjacent to neuronal synapses and astrocytic calcium stores20,21.
In vitro studies suggest that depletion of α2-Na/K ATPase in
astrocytes alters calcium signaling, whereas overexpression of α2-
Na/K ATPase in primary astrocytes leads to altered glutamate
uptake22,23. However, the specific in vivo roles of α2-Na/K
ATPase in astrocytes in the brain have remained to be elucidated.
The pathogenesis of familial hemiplegic migraine has been
investigated through analyses of patient-specific mutations in
mice24–30. Knock-in mice with the W887R patient-specific
mutation of α2-Na/K ATPase have provided insights into the
effect of the mutation on α2-Na/K ATPase function26,29.
Homozygous W887R knock-in mice fail to survive past embry-
ogenesis, whereas heterozygous W887R knock-in mice are
viable26. Analogously, the homozygous null mutation of α2-Na/K
ATPase leads to embryonic lethality, whereas mice bearing the
heterozygous null mutation of α2-Na/K ATPase are viable31,32.
These observations buttress the conclusion from in vitro studies
that the W887R mutation leads to the loss of function of α2-Na/K
ATPase8,26. Mice bearing patient-specific mutations of α2-Na/K
ATPase have also pointed to excessive glutamatergic neuro-
transmission in the pathogenesis of familial hemiplegic
migraine28–30. However, knock-in mice with patient-specific α2-
Na/K ATPase mutations have not displayed phenotypes of motor
impairment26,28–30. Consistent with this observation, although
abnormalities of induced cortical spreading depression (iCSD)
events, considered a pathophysiological correlate of migraine
aura33,34, have been observed in knock-in mice with patient-
specific α2-Na/K ATPase mutations, these mice have not exhib-
ited spontaneous CSD (sCSD) events26,28. Phenotypes of tran-
sient motor phenotypes or sCSD events relevant to familial
hemiplegic migraine have been thought to be too subtle to be
detected in α2-Na/K ATPase knock-in mice. On the other hand,
differences in the mouse and human brain may underlie the
absence of these phenotypes in knock-in mice with patient-
specific mutations of α2-Na/K ATPase.
In this study, we have unexpectedly found that mice in which
α2-Na/K ATPase is conditionally deleted in astrocytes display
episodic transient motor paralysis. Functional neuroimaging
analyses reveal that conditional knockout of α2-Na/K ATPase
triggers sCSD events in the brain. The sCSD events associate with
low-voltage activity (LVA) events upon EEG monitoring. Long-
term video and EEG monitoring show that LVA events correlate
with transient motor impairment in conditional α2-Na/K ATPase
knockout mice. In mechanistic studies, transcriptomic and
metabolomic analyses reveal that the loss of α2-Na/K ATPase
alters metabolic gene expression in astrocytes in vivo, with
consequent elevation of serine and glycine in the brain.
Remarkably, feeding conditional α2-Na/K ATPase knockout mice
a diet free of serine and glycine reverses the phenotype of tran-
sient motor impairment. Notably, conditional α2-Na/K ATPase
knockout mice also exhibit weight loss and die prematurely
during adulthood, phenotypes that are not observed in familial
hemiplegic migraine, and these phenotypes are not reversed by
the serine- and glycine-free diet. Collectively, our findings define
a metabolic mechanism regulated by astrocytic α2-Na/K ATPase
that triggers episodic transient motor paralysis in mice, with
potential implications for understanding episodic neurological
disorders in the human brain.
Results
Conditional α2-Na/K ATPase knockout mice display episodic
transient paralysis. To characterize the function of α2-Na/K
ATPase in the brain, we generated conditional α2-Na/K ATPase
knockout mice. Because α2-Na/K ATPase is predominately
expressed in astrocytes in the brain17, we crossed mice harboring
the floxed allele of the α2-Na/K ATPase gene ATP1a2 (α2-Na/K
ATPaseloxP/loxP) with mice expressing the recombinase Cre under
control of the murine GFAP (mGFAP) promoter. Using Cre-
dependent EYFP transgenic mice, we confirmed selective
expression of Cre in S100β-positive astrocytes, but not neurons in
the cerebral cortex in postnatal day 20 (P20) old mice (Supple-
mentary Fig. 1a–c). Immunoblotting and RT-qPCR analyses
showed robust downregulation of α2-Na/K ATPase protein and
mRNA in the cerebral cortex of conditional α2-Na/K ATPase
knockout mice (Fig. 1a, b and Supplementary Fig. 2a–e). Cortical
α2-Na/K ATPase protein levels were significantly reduced at P24
(17.7 ± 4.27% of Ctrl, p < 0.01) and modestly more reduced at P78
(4.37 ± 1.69% of Ctrl, p < 0.001 and p < 0.01 when comparing P24
and P78, Supplementary Fig. 2a, d, e). In control analyses of
conditional α2-Na/K ATPase knockout mice, α2-Na/K ATPase
was not downregulated in skeletal muscle (Supplementary
Fig. 2f). In addition, conditional α2-Na/K ATPase knockout had
little or no effect on the levels of α1-Na/K ATPase or α3-Na/K
ATPase in the cerebral cortex (Supplementary Fig. 2g, h).
Conditional α2-Na/K ATPase knockout mice were born in a
Mendelian ratio and appeared normal until around 1 month of
age (Supplementary Fig. 3a, b). Unexpectedly, starting ~P30–P40,
conditional α2-Na/K ATPase knockout mice frequently fell onto
their side or abdomen and were unable to right themselves
transiently for seconds to hours (Fig. 1c and Supplementary
Movies 1–4). The episodes of paralysis appeared in all conditional
α2-Na/K ATPase knockout mice, but not in control or
conditional α2-Na/K ATPase heterozygous mice (Fig. 1d). In
longitudinal video monitoring, the average amount of time of
transient paralysis of conditional α2-Na/K ATPase knockout mice
increased with age (Fig. 1e). Conditional α2-Na/K ATPase
knockout mice also exhibited deficits in an accelerating rotarod
paradigm including prior to onset of transient paralysis (Fig. 1f).
Notably, conditional α2-Na/K ATPase knockout mice demon-
strated significantly reduced weight beginning around the time of
paralysis onset and had shortened lifespan at later ages
(Supplementary Fig. 3c, d). The paralysis and lifespan phenotypes
were similar in male and female conditional α2-Na/K ATPase
knockout mice (Supplementary Fig. 3e–g).
Reversible paralysis caused by dysfunction of the central
nervous system is typically associated with cerebrovascular
ischemia or may occur in the aftermath of seizure activity35. No
apoptotic cell death was evident in the cerebral cortex on
immunohistochemical analyses, using antibodies to cleaved
caspase-3 and a TUNEL assay (Fig. 1g, h). Likewise, hematoxylin
and eosin (H/E) analyses revealed normal appearance of the
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cerebral cortex in conditional α2-Na/K ATPase knockout mice
with no evidence of ischemic events (Fig. 1i). Continuous EEG
monitoring, which has been successfully used to detect seizures in
mice36–38, failed to reveal seizure activity coincident with or
surrounding transient paralysis events, though one ictal event was
observed in over 4000 mouse hours in conditional α2-Na/K
ATPase knockout mice (Supplementary Fig. 3h). These data
suggest that neither ischemia nor generalized seizures causes
transient paralysis in conditional α2-Na/K ATPase knockout mice.
Induced cortical spreading depression spreads faster in con-
ditional α2-Na/K ATPase knockout mice. Because loss of-
function α2-Na/K ATPase mutations cause episodic neurological
symptoms and signs, including transient paralysis in patients
with familial hemiplegic migraine7, we reasoned that episodes of
paralysis in conditional α2-Na/K ATPase knockout mice might
represent a phenomenon similar to migraine aura. Migraine aura
is thought to be associated with cortical spreading depression
(CSD), a wave of depolarization followed by hyperpolarization
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Fig. 1 Conditional α2-Na/K ATPase knockout mice display spontaneous transient paralysis. a Lysates of the cerebral cortex from P6, P12, P24, and P78
conditional α2-Na/K ATPase knockout (cKO) and sex-matched littermate f/f or f/+ control (Ctrl) mice were immunoblotted with α2-Na/K ATPase and
actin antibodies, the latter serving as loading control (n= 3 mice per group, quantification in Supplementary Fig. 2, full blots in Supplementary Fig. 15).
b Lysates of the cerebral cortex from cKO or Ctrl mice at each age were subjected to qRT-PCR analyses using primers to α2-Na/K ATPase, normalized to
Gapdh. Gapdh levels did not differ between groups (Supplementary Fig. 14a). Data are presented as mean ± s.e.m. ***P < 0.001 (two-way ANOVA followed
by Fisher’s LSD post hoc test). c–e cKO, Ctrl, and conditional α2-Na/K ATPase heterozygous (cHet) mice were subjected to paralysis video monitoring. A
representative trace from a P48 cKO mouse is shown (c). Shaded green regions represent paralysis. Quantification of video monitoring from conditional
cKO, Ctrl, and cHet showing number of paralysis bouts (d). Note that no cHet/Ctrl mice ever exhibited an episode of paralysis. Data are presented as
mean ± s.e.m. ***P < 0.001 (two-tailed t test, n= 7 Ctrl mice, 8 cHet mice, 8 cKO mice—3 male, 5 female, P= 0.0005). Quantification of video monitoring
from cKO mice, showing total percentage time paralyzed (e). Data are presented as mean ± s.e.m. (n= 8 mice per group). f cKO, Ctrl, and cHet mice were
subjected to an accelerating rotarod test. *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA followed by Fisher’s LSD post hoc test comparing Ctrl and
cKO, n= 6 mice per group—4 male, 2 female). g Representative images from cleaved caspase-3 staining from 50–75-day-old cKO and Ctrl mice. Sections
from EtOH-injected Ctrl mice served as positive control. Scale bar is 100 µm; (n= 2). h Representative images of sections of the cerebral cortex from
50–75-day-old cKO and Ctrl mice subjected to TUNEL staining. DNase-treated Ctrl sections served as positive control. Scale bar is 500 µm; (n= 3).
i Representative images from hematoxylin and eosin staining from 50–75-day-old cKO and Ctrl mice. Scale bar is 100 µm; (n= 3).
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spreading at a slow rate (3–5 mm/min) in the cerebral cortex39.
In animals, CSD events may be induced upon dural pinprick of
the brain40. We developed a paradigm to image CSD in vivo
using intrinsic optical signal (iOS) and neuronal calcium ima-
ging41, the latter using the genetic calcium indicator GCaMP6f
under control of the Thy1 promotor (Fig. 2a). First, we showed
that dural pinprick induces CSD events, and that the speed
measurements for total hemoglobin and neuronal calcium clo-
sely match the speed of spread measured by EEG electrodes
(Fig. 2b, Supplementary Fig. 4). Then, using the same paradigm,
we observed that induced cortical spreading depression (iCSD)
events were significantly increased in speed in the brain of
conditional α2-Na/K ATPase knockout mice, when compared to
control mice at both P24 and P50 (Fig. 2c–f, and Supplementary
Figs. 5 and 6).
Spontaneous cortical spreading depression in conditional α2-
Na/K ATPase knockout mice correlates with transient motor
paralysis. Because conditional α2-Na/K ATPase knockout mice
featured the phenotype of spontaneous transient paralysis, we
asked whether spontaneous cortical spreading depression (sCSD)
events might arise in the brain of these mice. To capture potential
sCSD events, we imaged unanesthetized conditional α2-Na/K
ATPase knockout and control mice longitudinally for 90 min
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Fig. 2 Induced cortical spreading depression spreads faster in conditional α2-Na/K ATPase knockout mice. a–e P24 conditional α2-Na/K ATPase
knockout (cKO) and sex-matched littermate f/f or f/+ controls (Ctrl) mice expressing Thy1-GCaMP6f were anesthetized, subjected to a small craniotomy
placed over the posterior right hemisphere and imaged for three trials after a pinprick of the dura. The average signal at each y point on the brain, for each
point in time, is made into an image (position-time plot, (d)) where the image color represents the signal, y-axis represents the brain y-position and x-axis
represents time (b). These images were used to calculate CSD speed. Traces illustrating mean ± s.e.m. for all included induced CSD trials (c). HbO
oxygenated hemoglobin, HbR deoxygenated hemoglobin, HbT total hemoglobin, [Ca] neuronal calcium. Total time = 600 s; (n= 6 mice per group).
Position-time plots of representative example CSD events from cKO and Ctrl animals (d). CSD peak spread significantly faster in the P24 cKO mice, in both
the total hemoglobin and neuronal calcium traces (e). All iCSD position-time plots are shown in Supplementary Fig. 5 for P24. Filled in black circles
represent speed for each CSD and statistics are calculated from this data, hollow blue circles represent the mean speed for each mouse. Data are presented
as mean ± s.e.m. *P < 0.05, **P < 0.01 (two-tailed t test, n= 6 mice per group—3 female, 3 male and 14 CSDs in Ctrl, 15 CSDs in cKO, total Hgb= 4.61 ±
0.21 in Ctrl, 5.95 ± 0.40 in cKO, P= 0.030, neuronal Ca= 5.40 ± 0.24 in Ctrl, 6.25 ± 0.29 in cKO, P= 0.034). f CSD peak spread significantly faster in the
hemoglobin trace for the P50 cKO mice. All iCSD position-time plots are shown in Supplementary Fig. 6 for P50. Filled in black circles represent speed for
each CSD and statistics are calculated from this data, hollow blue circles represent the mean speed for each mouse. Data are presented as mean ± s.e.m.
*P < 0.05 (two-tailed t test, n= 3 mice per group—2 female, 1 male and 8 CSDs in Ctrl, 9 CSDs in cKO, total Hgb= 4.74 ± 0.36 in Ctrl, 6.85 ± 0.86 in cKO,
P= 0.047).
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described (Fig. 3a)41. Strikingly, we detected robust sCSD events
in conditional α2-Na/K ATPase mice, whereas no sCSD events
were observed in control mice (Fig. 3b). The frequency of sCSD
events in conditional α2-Na/K ATPase knockout mice was 0.10/h
± 0.04, consistent with the frequency of transient paralysis (0.12
± 0.23, P= 0.644), suggesting that sCSD events might be asso-
ciated with episodes of motor impairment. Notably, sCSD events
included unilateral and bilateral events with distinct origins and
directions of spread (Fig. 3c–f, Supplementary Fig. 7, and Sup-
plementary Movies 5–11). Speed estimates for sCSD events yiel-
ded on average faster speeds than those measured during iCSD
events (Supplementary Fig. 8). In both sCSD events and iCSD
events, alterations in blood flow and neuronal activity appeared to
be time-locked (Fig. 3d, e, Supplementary Fig. 6, and Supple-
mentary Movies 5–11). Collectively, our data reveal that CSD
events appear spontaneously in the brain of conditional α2-Na/K
ATPase knockout mice.
Cortical spreading depression is highly associated with LVA on
EEG analyses in patients42. EEG recordings in conditional α2-Na/
K ATPase knockout mice revealed that sCSD events were also
associated with periods of LVA (Fig. 3c, f and Supplementary
Fig. 7). LVA EEG events were not detected outside of sCSD
events in conditional α2-Na/K ATPase knockout mice or in
control mice. These analyses showed that periods of LVA in EEG
analyses correlated with sCSD events, suggesting that the EEG
alteration might be used as a surrogate of sCSD events in
conditional α2-Na/K ATPase mice.
The identification of sCSD events in awake conditional α2-Na/
K ATPase knockout mice led us next to determine whether these
events accompanied episodes of transient paralysis. Using
implanted bilateral cortical electrodes, we recorded EEG activity
and behavior simultaneously (Fig. 3g). In these analyses, periods
of LVA occurred in conditional α2-Na/K ATPase knockout mice
at a frequency of 0.04/h ± 0.01 (Fig. 3h), a similar frequency as
sCSD events (Fig. 3b, 0.10 ± 0.04, P= 0.1307). Intersecting
analyses of behavior with EEG telemetry, we found that periods
of LVA on EEG were associated with transient abnormal motor
behavior, including paralysis, abnormal stationary posture, and
ataxia (Fig. 3i, j). Notably, bihemispheric LVA was strongly
associated with paralysis, whereas unilateral LVA was more
commonly associated with abnormal stationary posture and to a
lesser extent ataxia (Fig. 3k). Together, our data suggest that sCSD
events accompany transient impaired motor behavior in condi-
tional α2-Na/K ATPase knockout mice.
Alterations of metabolic gene expression in astrocytes in con-
ditional α2-Na/K ATPase knockout mice. Having characterized
an association between CSD and transient paralysis in conditional
α2-Na/K ATPase knockout mice, we next determined a
mechanism by which loss of α2-Na/K ATPase leads to the
pathogenesis of motor impairment in these mice. We first per-
formed RNA-Seq analyses in the cerebral cortex in conditional
α2-Na/K ATPase knockout and control mice at P24, prior to
onset of the phenotype of transient paralysis (Fig. 1e). We found
nearly 600 deregulated (411 upregulated and 187 downregulated)
genes in the cerebral cortex upon conditional knockout of α2-Na/
K ATPase (Fig. 4a and Supplementary Data 1). Gene ontology
(GO) analyses revealed that metabolism genes were over-
represented among the upregulated genes in P24 conditional α2-
Na/K ATPase knockout mice (Fig. 4b). The astrocytosis gene
Gfap was also upregulated in the brain of conditional α2-Na/K
ATPase knockout mice (Supplementary Fig. 9a). Gfap protein
upregulation was confirmed in immunohistochemical analyses,
and other astrocytosis genes were also upregulated on RT-qPCR
(Supplementary Fig. 9b, c)43. Remarkably, RNA-Seq and RT-
qPCR analyses of the cerebral cortex in P17 mice revealed
deregulation of metabolism, but not astrocytosis genes (Supple-
mentary Fig. 9d–f and Supplementary Data 1), suggesting loss of
α2-Na/K ATPase leads to alterations of metabolic gene expression
prior to onset of astrocytosis in conditional α2-Na/K ATPase
knockout mice. Among the most upregulated metabolism genes
at P17 were those encoding a glycine synthesis enzyme, a mito-
chondrial citric acid cycle enzyme, and glutamate transaminase
(Supplementary Fig. 9f).
To determine whether the deregulation of metabolic gene
expression occurs in a cell-intrinsic manner in conditional α2-Na/
K ATPase knockout mice, we performed translating ribosome
affinity purification (TRAP) analyses of the cerebral cortex from
mice, in which the EGFP/Rpl10a fusion protein was expressed in
a Cre-dependent manner using the mGFAP-Cre driver. TRAP
analyses in control mice led to the enrichment of genes selectively
expressed in astrocytes and de-enrichment for genes expressed in
neurons, microglia, and endothelial cells (Fig. 4c–e), validating
the TRAP approach. Expression of α2-Na/K ATPase mRNA was
nearly completely (98.2%) downregulated in TRAP analyses of
conditional α2-Na/K ATPase knockout mice (Fig. 4f, g),
confirming knockout of α2-Na/K ATPase in astrocytes. Impor-
tantly, metabolic genes including those that encode amino acid
metabolism were deregulated in astrocytes in the cerebral cortex
in conditional α2-Na/K ATPase knockout mice (Fig. 4h and
Supplementary Data 1). Together, our data show that metabolic
gene expression is deregulated in astrocytes in conditional α2-Na/
K ATPase knockout mice.
Levels of serine and glycine are elevated in the cerebral cortex
in conditional α2-Na/K ATPase knockout mice. To elucidate
the consequences of deregulated metabolic gene expression in the
brain upon loss of α2-Na/K ATPase, we performed metabolomics
analyses in the cerebral cortex of conditional α2-Na/K ATPase
knockout and control mice. Strikingly, the amino acid serine was
the most significantly altered metabolite in the cerebral cortex
upon conditional knockout of α2-Na/K ATPase in mice at both
P17 and P24, increasing more than twofold at P24 (Fig. 5a, b).
Other amino acids, including notably glutamate, were not sig-
nificantly altered, though glutamine was slightly downregulated
(Supplementary Fig. 10a–c). Targeted gas chromatography–mass
spectrometry (GC–MS) confirmed upregulation of serine in the
cerebral cortex, but not liver, in conditional α2-Na/K ATPase
mice (Fig. 5c and Supplementary Fig. 10d). Unlike in conditional
knockout mice, conditional heterozygous mice exhibited no sig-
nificant increase in cortical serine levels (Supplementary Fig. 10e).
In high-performance liquid chromatography (HPLC) assays, both
L- and D-enantiomers of serine were equivalently upregulated in
the brain of conditional α2-Na/K ATPase mice (Fig. 5d).
To shed light on the mechanisms by which loss of α2-Na/K
ATPase triggers the elevation of serine levels in the brain, we
constructed a network by integrating established metabolic path-
ways relevant to serine biosynthesis with our TRAP-Seq data
(Fig. 5e). These analyses revealed that several significantly
upregulated enzymes represent components of the folate cycle,
which relies on the interconversion of serine and glycine for carbon
units44. These genes included serine hydroxymethyltransferase 1
and 2, aldehyde dehydrogenase 1 family member L2, glycine C-
acetyltransferase, and methylenetetrahydrofolate dehydrogenase 2
(Shmt2, Shmt1, Aldh1l2, Gcat, and Mthfd1, Fig. 5e, f). Enzymes
that promote serine biosynthesis from glucose, such as phospho-
glycerate dehydrogenase, phosphoserine aminotransferase 1, and
phosphoserine phosphatase were downregulated or unaltered
(Fig. 5e, f). Because glycine is intimately involved with serine in
the pathways altered upon loss of α2-Na/K ATPase (Fig. 5e), we
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Fig. 3 Spontaneous cortical spreading depression in conditional α2-Na/K ATPase knockout mice correlates with transient motor paralysis.
a–h Conditional α2-Na/K ATPase knockout mice (cKO) and Ctrl mice were monitored for spontaneous cortical spreading depression (sCSD) events in
intrinsic optical signal imaging for total hemoglobin, with GCaMP6f imaging for neuronal calcium in a subset, and right hemispheric EEG recording (n= 6
Ctrl, 6 cKO mice, 3 male and 3 female, 81 Ctrl and 75 cKO hours). Frequency of sCSD events in cKO and Ctrl mice (b). No sCSD events were observed in
Ctrl mice. Data are presented as mean ± s.e.m. *P < 0.05 (two-tailed t test, n= 6 mice per group, P < 0.0001). Table of all observed sCSD events (c). LVA
low-voltage activity. Green box indicates pictured sCSD7 (d–f). The position-time plots for example sCSD in d with propagation of signal over time is
shown in e. The shaded box on f corresponds to the time captured by the still images (d) and the black bar (e, total time= 90 s, start at 50 s, 10 s between
images). g–k cKO and Ctrl mice were monitored for low-voltage activity (LVA) events with continuous bilateral EEG and video monitoring. Frequency of
observed LVA events in conditional cKO and Ctrl mice (h). No LVA events were observed in Ctrl mice. Data are presented as mean ± s.e.m. *P < 0.05 (two-
tailed t test, n= 6 Ctrl mice—3 male, 3 female, 7 cKO—5 male, 2 female, P < 0.0001). Frequency of LVA events in cKO mice (h) does not differ from
frequency of sCSD events (b, two-tailed t test, P= 0.1307). An example LVA event (i). Shaded box indicates LVA in right and left hemispheres, green trace
indicates paralysis. LVA events in cKO mice correlated with abnormal motor behavior (j). Proportions of normal (eating, sleeping, and walking) and
abnormal behavior (abnormal posture, abnormal walking, and paralysis) in cKO mice during normal EEG and LVA events. ***P < 0.001 (Chi-squared test, n
= 130 events in seven mice each, P < 0.0001). Breakdown of behaviors during normal EEG and LVA, and unilateral vs. bilateral LVA (abnormal behavior=
colors, normal behavior= grayscale, n= 130 events, 62 unilateral 68 bilateral, in seven mice) (k).
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performed GC–MS analyses of glycine in conditional α2-Na/K
ATPase knockout mice. Like serine, glycine was upregulated in the
cerebral cortex, but not liver, of conditional α2-Na/K ATPase
knockout mice (Fig. 5g and Supplementary Fig. 10f).
Because Na/K ATPase activity may influence mitochondrial
metabolism via altered calcium dynamics11,22,45, and mitochondrial
dysfunction deregulates serine biosynthesis46, we asked whether loss
of α2-Na/K ATPase in the conditional knockout mice might impact
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Fig. 4 Conditional α2-Na/K ATPase knockout mice exhibit alteration of metabolic transcripts in astrocytes. a, b The cerebral cortex from P24
conditional α2-Na/K ATPase knockout (cKO) and sex-matched littermate f/f or f/+ control (Ctrl) mice were subjected to RNA-Seq analyses (n= 4).
Clustering dendrogram and heatmap of the expression levels of significantly upregulated and downregulated genes (false discovery rate (FDR) < 0.05, n=
4 mice per group, Z-score of base 2 log-transformed CPM) (a). Gene ontology (GO) analyses of, from left to right, differentially expressed and upregulated
genes in the P24 cKO mice (b). Significantly overrepresented pathways are shown (FDR < 0.05, equivalent to negative base 10 log-transformed FDR >
1.301). c–h The cerebral cortex from P24 cKO and Ctrl mice were subjected to translating ribosome affinity purification-Seq (TRAP) followed by sequencing
(TRAP-Seq) analyses; (n= 3 mice per group). Enrichment of canonical astrocyte marker genes and de-enrichment of canonical marker genes of other cell
types in the immunoprecipitation (IP) fraction of f/f or f/+ Ctrl mice, using an antibody to GFP, relative to input for TRAP-Seq (d, e). Data are presented as
mean ± s.e.m. ***P < 0.001 (two-tailed t test, n= 3 mice per group). Clustering dendrogram and heatmap of the expression levels of significantly
upregulated and downregulated genes in the IP fraction from cKO mice compared to the IP fraction from sex-matched Ctrl mice (f) (FDR < 0.05, n= 3 mice
per group, Z-score of base 2 log-transformed CPM). Atp1a2 transcript levels in Ctrl and cKO IP samples (g). Data are presented as mean ± s.e.m. ***P <
0.001 (t test, n= 3 mice per group, P= 0.0007). Top six pathways (by FDR) for GO analyses of differentially expressed genes in the P24 cKO mice relative
to sex-matched littermate Ctrl mice (h). Significantly overrepresented pathways are shown (FDR < 0.05, equivalent to negative base 10 log-transformed
FDR > 1.301).
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mitochondrial function. We first characterized the morphology of
mitochondria in astrocytes in the cerebral cortex in P24 conditional
α2-Na/K ATPase knockout mice (Supplementary Fig. 11a). A
modest but significant increase in the proportion of mitochondria
with abnormal morphology was evident in the cortex upon
conditional knockout of α2-Na/K ATPase (Supplementary Fig. 11a).
In other analyses, mitochondrial genes were significantly enriched
among the deregulated, mostly upregulated genes in astrocytes
obtained in TRAP-Seq analyses upon intersection with the
MitoCarta database of 1158 verified mitochondrial genes (Supple-
mentary Fig. 11b, c and Supplementary Data 1)47. The upregulated
mitochondrial function transcripts in conditional α2-Na/K ATPase
knockout mice encoded serine and glycine biosynthesis, including
Shmt2, Mthfd2 and Aldh1l2, and Gatm (Supplementary Fig. 11d
and Supplementary Data 1). Construction of a network encom-
passing all metabolites significantly altered at P24 or P17 (Fig. 5a, b)
P24 TRAP-Seq: enzyme transcript levels 
*** *** *** *** * *** ** ** ** ***
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Fig. 5 Levels of serine and glycine are elevated in the cerebral cortex of conditional α2-Na/K ATPase knockout mice. a Metabolomics was performed
on flash-frozen cerebral cortex from P17 conditional α2-Na/K ATPase knockout (cKO) and sex-matched littermate f/f or f/+ control (Ctrl) mice. Only
significantly altered metabolites are shown. Data are presented as mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001 (two-tailed t test, n= 6 mice per
group). bMetabolomics was performed on flash-frozen cerebral cortex from P24 cKO and Ctrl mice. Only significantly altered metabolites are shown. Data
are presented as mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001 (two-tailed t test, n= 6 mice per group). c The cerebral cortex from perfused P24 and P17
cKO and Ctrl mice was subjected to gas chromatography–mass spectrometry (GC–MS) for serine levels. The levels of serine were robustly elevated in the
cerebral cortex of conditional α2-Na/K ATPase knockout mice. Data are presented as mean ± s.e.m. *P < 0.05, ***P < 0.001 (two-tailed t test, n= 4 mice
per group, P= 0.046 P17, P= 0.00056 P24). d Flash-frozen cerebral cortex from P24 cKO and Ctrl mice was subjected to high-performance liquid
chromatography (HPLC) to quantify levels of D- and L-serine. Data are presented as mean ± s.e.m. ***P < 0.001 (two-tailed t test, n= 4 mice per group,
P= 0.00034 D-serine, P= 0.00058 L-serine). e Network constructed by integrating established metabolic pathways relevant to serine biosynthesis with
TRAP-Seq data for transcript levels of metabolic enzymes and the metabolomics data for metabolite levels. Red indicates significant upregulation (P <
0.05), blue indicates significant downregulation, black indicates no significant change, and gray indicates an unmeasured metabolite. f Fold change of
selected metabolic enzymes in the TRAP-Seq for cKO relative to Ctrl mice. Data are presented as mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001 (false
discovery rate (FDR), n= 3 mice per group). g The cerebral cortex from perfused P24 and P17 cKO and Ctrl mice was subjected to GC–MS for
glycine levels. The levels of glycine were robustly elevated in the cerebral cortex of conditional α2-Na/K ATPase knockout mice. Data are presented as
mean ± s.e.m. *P < 0.05, **P < 0.01 (two-tailed t test, n= 4 mice at P17, 8 at P24, P= 0.020 P17, P= 0.0035 P24).
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with TRAP-Seq gene expression changes showed that altered
metabolites participate in mitochondrial pathways, including the
citric acid cycle and folate/1-carbon metabolism, or in purine and
pyrimidine salvage pathways, which occur in the cytoplasm but are
dependent on mitochondrial folate cycle cofactors (Supplementary
Fig. 11e). Taken together, our results suggest that loss of α2-Na/K
ATPase leads to alterations of mitochondrial metabolism, and
elevation of levels of serine and glycine in the brain.
Serine- and glycine-free diet reverses episodic transient motor
paralysis in conditional α2-Na/K ATPase knockout mice. To
determine the significance of elevation of serine and glycine levels
in the pathogenesis of transient motor paralysis, we assessed the
effect of lowering the levels of these amino acids on the motor
phenotype in conditional α2-Na/K ATPase mice. Beginning at
P17, we fed control mice one of four diets: control diet, serine-
free diet, glycine-free diet, or serine- and glycine-free diet
(Fig. 6a). Unlike the serine-free and glycine-free diets, the diet
free of both serine and glycine substantially reduced the levels of
serine and glycine in the cerebral cortex and liver in control mice
(Fig. 6b). Conditional α2-Na/K ATPase mice fed the serine- and
glycine-free diet likewise exhibited reduced levels of cortical and
liver serine and glycine (Supplementary Fig. 12a, b). Conditional
α2-Na/K ATPase knockout mice fed the control or serine- and
glycine-free diet were both viable with no significant differences
in their weight (Supplementary Fig. 12c, d). However, in analyses
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Fig. 6 Serine- and glycine-free diet reverses motor paralysis and ataxia in conditional α2-Na/K ATPase knockout mice. a, b Sex-matched littermate f/f
or f/+ control (Ctrl) mice were weaned at P17 onto one of the following diets: Ctrl, serine-free (S-free), glycine-free (G-free), or serine- and glycine-free
(SG-free). The cerebral cortex and liver collected from P40 perfused Ctrl mice on Ctrl, S-free, G-free, and SG-free food were subjected to GC–MS for serine
and glycine levels (b). The SG-free diet reduced the levels of serine and glycine substantially in the cerebral cortex and liver in Ctrl mice. Data are presented
as mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001 (two-tailed t test, n= 4 mice per group). c–e Sex-matched littermate conditional α2-Na/K ATPase
knockout (cKO) mice were weaned onto Ctrl or SG-free diet at P17 and weighed daily thereafter. Daily rotarod analyses and every other day monitoring for
motor paralysis of mice was begun at P30. Left: mean latency to fall on constant velocity rotarod task for cKO mice on Ctrl or SG-free diet (d). Data are
presented as mean ± s.e.m. (n= 11 mice per group starting at P17). Right: a subset of data from left side shown for clarity. Data are presented as mean ±
s.e.m. **P < 0.01, ***P < 0.001 (two-way ANOVA followed by Fisher’s LSD post hoc test, n= 11 mice per group starting at P17—4 males, 7 females). Left:
percentage of time paralyzed for sex-matched littermate conditional α2-Na/K ATPase knockout mice (cKO) on Ctrl or SG-free food (e). Data are
presented as mean ± s.e.m. ***P < 0.001 (two-tailed t test, n= 11 mice per group starting at P17). Right: a subset of data from left side shown for clarity.
The serine- and glycine-free diet reversed transient motor paralysis in conditional α2-Na/K ATPase knockout mice. Data are presented as mean ± s.e.m.
***P < 0.001 (two-way ANOVA followed by Fisher’s LSD post hoc test, n= 11 mice per group starting at P17—4 males, 7 females). f Survival was
modestly, albeit significantly, extended in cKO mice on SG-free food compared to Ctrl food. ***P < 0.001 (log-rank (Mantel–Cox) test, n= 17 mice per
group—6 males, 11 females, P= 0.0008).
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glycine-free diet dramatically improved the motor performance of
conditional α2-Na/K ATPase mice (Fig. 6c, d). Strikingly, whereas
conditional α2-Na/K ATPase knockout mice on control diet
displayed episodic paralysis, these mice displayed no bouts of
transient paralysis when fed the serine- and glycine-free diet
(Fig. 6e). The remarkable salutary effect of the serine- and
glycine-free diet in conditional α2-Na/K ATPase mice was evi-
dent >1 month after onset of the motor phenotype in the control
diet cohort (Fig. 6e). When followed until their death, conditional
α2-Na/K ATPase knockout mice on the serine- and glycine-free
diet did not reach the levels of paralysis or rotarod impairment
observed in littermate conditional α2-Na/K ATPase knockout
mice on control diet (Supplementary Fig. 12e, f). Interestingly,
although the serine- and glycine-free diet reversed the phenotype
of transient motor paralysis in conditional α2-Na/K ATPase
knockout mice, the survival of these mice was only modestly,
albeit significantly, improved compared to conditional knockout
mice on control diet (Fig. 6f). In control experiments, wild-type
mice on either the control or serine- and glycine-free diet had no
paralysis or impairment on rotarod, though the serine- and
glycine-free diet led to some weight loss in control mice (Sup-
plementary Fig. 12g–i). In other analyses, conditional α2-Na/K
ATPase knockout mice fed the serine- and glycine-free diet that
were switched to control diet at P40 displayed episodic transient
paralysis, and impaired rotarod performance at P50 and P60
compared to conditional α2-Na/K ATPase knockout mice
maintained on the serine- and glycine-free diet (Supplementary
Fig. 13). We conclude that lowering serine and glycine levels in
the brain selectively reverses the phenotype of transient motor
paralysis in conditional α2-Na/K ATPase mice, establishing the
critical role of serine and glycine elevation in the pathogenesis of
transient motor paralysis in these mice.
Discussion
In this study, we have discovered a metabolic mechanism by
which loss of α2-Na/K ATPase in astrocytes triggers transient
motor paralysis and sCSD in mice. We have found that mice in
which α2-Na/K ATPase is conditionally deleted in astrocytes
display the unexpected phenotype of episodic transient motor
paralysis. In functional imaging studies, conditional knockout of
α2-Na/K ATPase triggers sCSD events, a hallmark of migraine
aura. The sCSD events in conditional α2-Na/K ATPase knockout
mice are associated with LVA events upon EEG monitoring,
which in turn correlate with transient episodes of motor
impairments in these mice. In mechanistic studies, transcriptomic
and metabolomic analyses reveal that astrocytic knockout of α2-
Na/K ATPase induces alterations of metabolic gene expression in
astrocytes with associated elevation of the amino acids serine and
glycine in the brain. Strikingly, feeding mice a diet free of serine
and glycine reverses the phenotype of transient motor paralysis,
establishing a mechanistic link between elevation of serine and
glycine and transient motor paralysis. Our study defines a link
between the ion pump α2-Na/K ATPase and amino acid meta-
bolism in astrocytes in the brain, whose deregulation triggers
episodic transient motor paralysis in mice, with potential impli-
cations for understanding episodic neurological disorders in the
human brain.
We unexpectedly discovered that mice in which α2-Na/K
ATPase is conditionally deleted in astrocytes display episodic
transient motor paralysis. Mutations of α2-Na/K ATPase cause
familial hemiplegic migraine. Heterozygous knock-in mice bear-
ing patient-specific mutations of α2-Na/K ATPase have provided
insights into α2-Na/K ATPase function, bolstering the conclusion
that mutations of α2-Na/K ATPase in familial hemiplegic
migraine lead to loss of α2-Na/K ATPase function. However,
although heterozygous knock-in mice with patient-specific
mutations in α2-Na/K ATPase exhibit increased susceptibility
to experimentally iCSD events, these mice do not display spon-
taneous episodic neurological disturbances26,28–30. The absence
of episodic motor phenotypes in the α2-Na/K ATPase hetero-
zygous knock-in mice may reflect the low frequency of neuro-
logical disturbances in the disorder or differences in the mouse
and human brain. Notably, heterozygous conditional α2-Na/K
ATPase knockout mice do not exhibit spontaneous motor
impairment. The unexpected finding of spontaneous, episodic
transient motor paralysis in conditional α2-Na/K ATPase
knockout mice raises the question of whether these events might
be relevant to the transient neurological disturbances in familial
hemiplegic migraine. The correlation of transient motor impair-
ment in conditional α2-Na/K ATPase mice with sCSD events,
using the EEG surrogate of LVA suggests these events may be
related to hemiplegic migraine aura. However, the high frequency
of transient motor impairment, as well as the additional pheno-
types of weight loss and premature death in conditional α2-Na/K
ATPase mice leave open the possibility that transient motor
paralysis in these mice represents a distinct pathophysiological
process.
The identification of sCSD events in conditional α2-Na/K
ATPase knockout mice may advance our understanding of the
pathophysiology of migraine aura, which is associated with CSD
events39,40. Further mechanistic studies in conditional α2-Na/K
ATPase knockout mice should prove useful to address the fun-
damental question of how disruption of α2-Na/K ATPase activity
in all astrocytes leads to localized deregulation of brain function
in a CSD. The evaluation of total hemoglobin changes and neu-
ronal calcium imaging during sCSD in this study have demon-
strated the spatial heterogeneity of sCSD events, when compared
to iCSD events. Further technological advances in the future
should permit intrinsic optical signaling and wide-field GCAMP
imaging in freely behaving mice, leading to characterization of
how these specific spatial properties of CSD may correlate with
motor phenotypes.
The link between loss of α2-Na/K ATPase function, and elevation
of serine and glycine raises the question as to how α2-Na/K ATPase
controls the levels of these amino acids. Our transcriptomics and
metabolomics data suggest a role for gene expression alterations in
enzymes that regulate serine and glycine metabolism, and dereg-
ulation of mitochondrial function. In vitro studies have implicated
α2-Na/K ATPase in calcium signaling due to its association with the
sodium–calcium exchanger, and deregulation of calcium leads to
impairments in mitochondrial function11,20,22,45,48. Cellular stres-
sors including mitochondrial dysfunction, oxidative stress, hypoxia
and growth signals induce serine biosynthesis via changes in
expression of genes, such as Shmt2 and Mthfd2 (refs. 46,49,50), which
we have identified as deregulated in astrocytes upon conditional α2-
Na/K ATPase knockout. Future studies will be required to identify
the role of specific transcription factors that might couple loss of α2-
Na/K ATPase function with elevation of serine and glycine levels in
the brain.
An important aim of future work will be to delineate how
elevated serine and glycine levels in the brain trigger motor
impairment. Elevated cortical serine and glycine may increase
susceptibility of the brain to CSD. Because D-serine is a synaptic
NMDA receptor co-agonist, elevations in serine and related
molecules might contribute to hyperexcitability of cortex via an
increase of glutamatergic neurotransmission51. Consistent with
this possibility, excessive glutamatergic signaling has been
reported in knock-in mice bearing patient-specific mutations of
α2-Na/K ATPase26,28,29.
The identification of elevated serine and glycine as a critical
metabolic mechanism specifically in the pathogenesis of transient
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motor impairment rather than weight loss or premature death of
conditional α2-Na/K ATPase mice suggests that episodic tran-
sient motor paralysis and phenotypes of weight loss and pre-
mature death upon depletion of astrocytic α2-Na/K ATPase may
have distinct pathophysiological underpinnings. These observa-
tions also suggest a potential avenue for the investigation of
amino acid metabolism in patients with familial hemiplegic
migraine caused by α2-Na/K ATPase mutations, which may help
to answer the question of whether the motor phenotype in con-
ditional α2-Na/K ATPase mice is relevant to familial hemiplegic
migraine, and hence advance our understanding of the disorder.
Methods
Animals. All animal experiments were done according to protocols approved by the
Animal Studies Committee of Washington University School of Medicine and in
accordance with the National Institutes of Health guidelines. Mice were purchased
and maintained under pathogen-free conditions. Mice were kept on a 12 h on, 12 h
off light cycle with room temperature 20–26 °C and humidity 30–70%. mGFAP-
Cre mice were obtained from The Jackson Laboratory (JAX Stock No. 024098)52.
mGFAP-Cre mice were mated with Ai3 YFP reporter mice (from The Jackson
Laboratory, JAX Stock No. 007903)53 to generate mGFAP-Cre EYFP mice. mGFAP-
Cre;α2-Na/K ATPase loxP/+ mice were mated with α2-Na/K ATPase loxP/loxP mice54 to
generate conditional α2-Na/K ATPase knockout mice (cKO: mGFAP-Cre;α2-Na/K
ATPase loxP/loxP), conditional α2-Na/K ATPase heterozygous mice (cHet: mGFAP-
Cre;α2-Na/K ATPase loxP/+) and control mice (Ctrl: α2-Na/K ATPase loxP/loxP or α2-
Na/K ATPase loxP/+). Once paralysis in conditional α2-Na/K ATPase knockout mice
was frequent, we placed water gel and food on the cage bottom. Mice were monitored
by weight and were culled if they reached their humane end point: 70% of maximum
weight (survival= time to humane end point or death, whichever comes first). For
wide-field calcium imaging in neurons, we generated conditional α2-Na/K ATPase
knockout mice with GCaMP6f expression under the Thy1 driver (mGFAP-Cre;α2-
Na/K ATPase loxP/loxP;Thy1-GCaMP6f) and controls (α2-Na/K ATPase loxP/loxP or α2-
Na/K ATPase loxP/+;Thy1-GCaMP6f). Thy1-GCaMP6f mice were obtained from The
Jackson Laboratory (JAX Stock No. 024276)55. For TRAP-Seq experiments, we
generated conditional α2-Na/K ATPase knockout mice with mGFAP-Cre-driven
expression of EGFP fused to ribosomal protein unit L10A (JAX Stock No. 024750)56.
All strains were backcrossed to and maintained on the C57BL/6J (black 6, JAX Stock
No. 000664) strain of mice.
Antibodies. Antibodies to α2-Na/K ATPase (Immunoblot, 1:20,000, Millipore,
AB9094), α1-Na/K ATPase (Immunoblot, 1:5000, Thermo Fisher, MA3-928), α3-
Na/K ATPase (Immunoblot, 1:5000, Thermo Fisher, MA3-915), actin (Immuno-
blot, 1:500, Santa Cruz, SC8432), GFP (Immunofluorescence, 1:500, Abcam,
AB13970), NeuN (Immunofluorescence, 1:500, Abcam, AB177487), GFAP
(Immunofluorescence, 1:500, Millipore, MAB3402), S100β (Immunofluorescence,
1:500, Abcam, AB41548), Iba1 (Immunofluorescence, 1:500, Wako, 019-19741),
cleaved caspase-3 (Immunofluorescence, 1:500, Cell Signaling D175), and Alexa
Fluor-conjugated secondary antibodies (Immunofluorescence, 1:500, Invitrogen,
A11039, A11004, A11001, and A10042) were purchased.
Immunoblotting analyses. Immunoblotting analyses were performed using
standard techniques as previously described57. In brief, the cerebral cortex or
gastrocnemius muscle from sex-matched littermate mice was homogenized in 50
mM Tris buffer (pH 7.4), 100 mM NaCl, 1 mM EDTA, and a cocktail of protease
inhibitors and DTT. Equal concentrations were solubilized in SDS-loading buffer
using a sonicator to prevent oligomerization of Na/K ATPase protein. Lysates were
then subject to immunoblotting with antibodies to α1, α2, or α3-Na/K ATPase with
actin as a loading control.
Immunoblot quantification was performed in FIJI using standard techniques.
Mean gray value in an ROI of standardized area was calculated for each band,
which was normalized to the value from a surrounding background area. Then, the
mean intensity for the band of interest was divided by mean intensity for the
loading control band for each sample.
Immunofluorescence and hematoxylin and eosin staining. For immuno-
fluorescence studies, conditional α2-Na/K ATPase knockout and sex-matched lit-
termate f/f or f/+ control mice were anesthetized, and perfused with heparinized
PBS followed by 4% PFA. The brain was extracted, postfixed, sucrose embedded,
cryoprotected in 70% OCT in 30% sucrose, frozen, and sectioned into 30 µM
sections on a cryostat. Sections were blocked in blocking buffer (3% bovine serum
albumin, 10% normal goat serum, and 0.4% Triton-X in 1× PBS), stained overnight
with antibodies against GFP, NeuN, GFAP, S100β, Iba1, and cleaved caspase-3
followed by incubation in appropriate Alexa Fluor-conjugated secondary anti-
bodies, and imaged on a Nikon A1Rsi scanning confocal microscope. Cell nuclei
were labeled with the DNA dye Hoechst 33258. For positive control for cleaved
caspase-3 staining, cerebral cortices from mouse pups (P7–P21) injected
subcutaneously with 2.5 mL/kg 20% ethanol 26 and 24 h prior to perfusion were
used as a positive control for apoptosis. For H/E staining, the brain was extracted
and fixed overnight in 4% PFA, then fixed brains were paraffin embedded, sec-
tioned, and stained with H/E via standard methods.
RNA-Seq and RT-qPCR. These experiments were performed as described58 with
modifications. In brief, RNA was extracted from flash-frozen cerebral cortex of sex-
matched littermate mice using Trizol (Thermo Fisher) followed by RNeasy Mini
Kit (Qiagen) according to the manufacturers’ instructions. Each sample of RNA
was made from the cortex of one mouse. For sequencing, 5–10 µg of RNA was
reverse-transcribed with oligo-dT priming, and the cDNA was sequenced on an
Illumina HiSeq 2000 (Genome Technology Access Center, GTAC, and McDonnell
Genome Institute, MGI, at Washington University). Read mapping was performed
in Galaxy with RNA STAR using the MM10 reference genome, and gene differ-
ential expression was estimated with EdgeR in R. The Benjamini–Hochberg false
discovery rate was calculated for all genes; fold change and Z-scores were calculated
based on counts per million (CPM). GO was performed using PANTHER59,
Biological Process (Slim) unless otherwise specified. For qRT-PCR, real-time PCR
reactions were performed using Light cycler 480 SYBR Green 1 Master (Roche).
The following mouse gene primers were used: α2-Na/K ATPase forward: TTCGTA
GCATCGTGGTTGT, α2-Na/K ATPase reverse: CACCACGTGACCTTGAGTGG,
Gapdh forward: TGCTGGTGCTGAGTATGTCG, Gapdh reverse: GCATGTCAG
ATCCACAACGG, Gfap forward: AACCGCATCACCATTCCTGT, Gfap reverse:
TCCTTAATGACCTCGCCATCC, Vimentin forward: AGACCAGAGATGGACA
GGTGA, Vimentin reverse: TTGCGCTCCTGAAAAACTGC, Osmr forward: GTG
AAGGACCCAAAGCATGT, Osmr reverse: GCCTAATACCTGGTGCGTGT,
Srgn forward: GCAAGGTTATCCTGCTCGGA, Srgn reverse: TGGGAGGGCCG
ATGTTATTG, Serping1 forward: ACAGCCCCCTCTGAATTCTT, Serping1
reverse: GGATGCTCTCCAAGTTGCTC, Ggta forward: GTGAACAGCATGA
GGGGTTT, Ggta reverse: GTTTTGTTGCCTCTGGGTGT, Cd109 forward: CAC
AGTCGGGAGCCCTAAAG, Cd109 reverse: GCAGCGATTTCGATGTCCAC,
Emp1 forward: GAGACACTGGCCAGAAAAGC, Emp1 reverse: TAAAAGGC
AAGGGAATGCAC, Clcf1 forward: CTTCAATCCTCCTCGACTGG, Clcf1
reverse: TACGTCGGAGTTCAGCTGTG43.
All primers performed well with standard curves and efficiency/correlation
values for each pair shown in Supplementary Fig. 14. Standard curves were
generated and PCR efficiency/correlation coefficient for each qRT-PCR primer pair
as follows. A five-point twofold dilution series of cDNA was used to construct the
assay, with Ct values being calculated from the average of two technical replicates.
Ct values were plotted against the concentration of cDNA on a log scale, and a line
was fit to this graph (Microsoft Excel). The slope of the line was used to calculate
PCR efficiency (efficiency= 10(−1/slope)− 1) and the correlation coefficient was
measured from the degree of fit.
Behavioral analyses. For quantification of motor function, mice were subjected to
an accelerating or constant velocity rotarod test. For accelerating rotarod, mice were
placed on a rod which accelerated from 3 to 20 r.p.m. over 180 s. For constant velocity
rotarod, mice were placed on a rod which maintained 3 r.p.m. for 180 s. In both cases,
mice were trained on day 1, prior to testing, by testing them on a stationary rod, and
then at a constant 3 r.p.m. Mice passed training after staying on the stationary and
then the 3 r.p.m. rod for a total of 60 s over three trials. Mice were tested by measuring
their latency to fall for three trials, with an intertrial interval of ~10min, and then
averaging the three trials. For paralysis quantification, mice underwent video mon-
itoring for 4 continuous hours for the specified timepoints until experimental end
point or humane end point, whichever came first. Behavior was then scored, noting
exact times when paralysis began or ended (paralysis is defined as lying on side or
stomach and unable to right self within 60 s).
TUNEL staining. For tissue staining, cortices were fresh frozen in embedding
solution (70% tissue OCT+ 30% sucrose) and cut into 15 µm sagittal sections.
Sections were fixed by 4% paraformaldehyde for 20 min at room temperature,
permeabilized by 0.1 M citrate buffer (pH 6.0) at 80 °C, treated with DNase
working solution (10 µL 1000 U recombinant DNase+ 900 µL DNase Tris buffer)
for the positive control slice and tunnel labeling with 45 µL label solution together,
with 5 µL enzyme solution for 1 h at room temperature in the dark. Sections were
counterstained with Hoechst and mounted with Fluoromount before being
visualized (In Situ Cell Death Detection Kit, Fluorescein, Sigma-Aldrich).
Intrinsic optical signal imaging, wide-field calcium imaging, and EEG
recording. Mice were put under general isofluorane anesthesia, while an
anterior–posterior incision on the dorsal cortical surface was made to clear away
the scalp and periosteal membranes. Animals undergoing craniotomy had a 1 mm
diameter circle removed from the right posterior skull and were imaged immedi-
ately thereafter. Animals prepared for longitudinal imaging were implanted with
stainless steel EEG bone screws and transparent cortical plexiglass windows as
described41. Specifically, a unilateral right sided EEG screw was implanted −1 mm
posterior and 5 mm lateral to bregma with a reference EEG screw in the cere-
bellum. The plexiglass window was fixed to the intact skull with translucent dental
cement (C&B-Metabond, Parkell Inc, Edgewood, NY, USA), covering the cortical
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19915-2 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:6164 | https://doi.org/10.1038/s41467-020-19915-2 | www.nature.com/naturecommunications 11
surface spanning from the olfactory bulbs to the superior colliculus. Mice were
allowed 1 week to recover after surgery. EEG screws were attached to an amplifier
and signal was collected at 10,000 Hz (Power Lab EEG Amplifier, AD Instruments,
New Zealand) concurrent with iOS/fluorescence imaging. The mean EEG trace was
subtracted from the signal and the result was plotted with the accompanying iOS/
fluorescence data.
For iOS/fluorescence image acquisition, mice were suspended in a felt pouch or
stereotaxic frame with the head fixed under the imaging apparatus. Sequential
illumination of the cortex was provided by 454, 523, 595, and 640 nm LEDs (523,
595, and 640 nm used for iOS imaging; 454 nm used for GCaMP6f excitation); 523,
595, and 640 nm reflectance, as well as GCaMP6f fluorescence was recorded with a
high-powered, cooled, frame-transfer EMCCD camera (Andor) through an 85 mm
f/1.4 camera lens at 16.81 Hz per LED channel. A 515 nm longpass filter was used
to filter out GCaMP6f excitation light.
As described elsewhere60, with modifications briefly summarized here, the iOS/
GCaMP6f data was binned to 128 × 128 pixels at 78 μm2 per pixel (see “Code
availability” statement below for github link to the code described here). Data were
detrended and the mean trace for each channel was subtracted from the time series
data to remove ambient light levels that may be present. Data were resampled to 1
Hz and a binary brain mask representing brain regions is applied, and a spatial and
temporal detrending algorithm is used to correct for variance in light levels across
pixels or time. The binary mask and data were then affine transformed to common
atlas space. Data were mean normalized and the 523, 595, and 640 nm channels are
translated into oxygenated and deoxygenated hemoglobin using the modified
Beer–Lambert law. GCaMP6f fluorescence was corrected for hemodynamic
fluctuations using a ratiometric approach using the 523 nm reflectance data. All
data were smoothed with a 5 × 5 pixel Gaussian filter, and the global signal was
determined as the average signal from all pixels and regressed from the data to
control for global sources of variance.
For iCSD monitoring, mice were maintained under inhaled isoflurane
anesthesia for the duration of imaging. Experimenters were blinded to the genotype
of the mice. Mice underwent 10 min of baseline imaging, followed by three trials in
succession of a dural pinprick followed by 20 min of imaging. Trials in which a
CSD did not immediately follow the dural pinprick were discarded from further
analysis. For sCSD monitoring, mice underwent surgery at least 7 days prior to the
first imaging session. Mice were imaged for 90 min during each of the following age
intervals: P27–P30, P31–P34, P35–P38, P39–P42, P43–P46, P47–P50, P51–P54,
P55–P58, and P59–P62.
To calculate speed for CSDs, we did the following. For iCSD, since predominate
direction of spread was in the posterior to anterior direction, signal was converted
to a position-time plot by averaging the signal in the affected hemisphere for each y
pixel location and plotting that over time. A linear regression was then used to fit a
line to the peak of the signal. These lines are shown in Supplementary Figs. 5 and 6
for every data point included in the analysis. The slope of these lines was used to
estimate CSD speed by converting it from pixels per seconds to mm/min using our
measured 11 pixels/mm. To calculate EEG speed, we calculated the lag in minutes
between the two waveforms using a cross correlation and divided the distance
between electrodes in mm by that time. For sCSD events, since the CSDs could
arise from anywhere and spread any direction, we first viewed videos and
qualitatively determined the hemisphere of the CSD and whether it spread in the x-
axis, y-axis, or both. We then created position-time plots for the axis or axes of
spread in the appropriate hemisphere, and calculated speed as outlined for iCSD
events. The axis and hemisphere of spread are presented in a table in
Supplementary Fig. 8, as are all regression lines and speeds.
Continuous EEG and video recording. Conditional α2-Na/K ATPase knockout
male and female mice were obtained for EEG analysis (n= 7; 2 male, 5 female α2-
Na/K ATPase conditional knockout mice; n= 6; 3 male/3 female control). The
control EEG appeared normal after the first week of monitoring. Mice received
surgery for placement of EEG electrodes at P21. Custom wire EEG electrode sets
were constructed using five Teflon-coated stainless steel wires (76 µm bare dia-
meter) soldered to an electronic pin header and a micro screw. The soldered
contacts were covered with dental cement and the electrode set sterilized for
implantation. Mice were placed under 3–4% isoflurane on a stereotaxic frame with
a heating pad set to 36.5 °C until pedal withdraw reflex ceased. The skin was
prepared with betadine and alcohol wipes with isoflurane maintained at 1–1.5% for
the remainder of the procedure. After a midline vertical incision to expose the skull,
forceps, and 3% hydrogen peroxide were used to remove any connective tissue and
dry the skull for electrode placement. Burr holes for the frontal reference electrodes
were made (anterior +0.5 mm, lateral ±0.5 mm; bregma), using a micro drill with a
0.9 mm tip and screws were secured in the skull. Two bilateral active recording
electrodes were placed over the parietal cortex (posterior −2.5 mm, lateral ±1.5;
bregma) and a ground screw secured over the cerebellum (posterior −6.2 mm,
lateral ±0.5; bregma), using the same technique as the reference electrode. The
exposed skull, screws, and all wires were covered in a layer of dental cement
(SNAP, Parkell) with the pin header secured to the head for subsequent recording.
The skin was sutured around the exposed dental cement/pin header and tissue glue
(Vetbond, 3 M) used to close the remainder of the incision. Mice received
Buprenorphine (0.1 mg/kg) and recovered in a warmed chamber for 2 h then
placed in individual recording cages.
Groups of four mice in individual caging recovered from surgery for 48 h
prior to connection with a custom flexible cable attached to the exposed pin
header for recording. Due to their small size, EEG tethering significantly limits
mobility of α2-Na/K ATPase conditional knockout mice at 3 weeks of age. Thus,
3-week-old mice were monitored for an initial 48 h recording period then
untethered for the remainder of the week. Starting at 4 weeks of age, the mice
were tethered for continuous (24/7) video-EEG monitoring for the remainder of
the experiment. Bilateral cortical EEG signals were acquired using a referential
montage using Stellate acquisition software and amplifiers. Signals were amplified
at 10,000× with high-pass (0.5 Hz) and low-pass (100 Hz) filters applied. EEG
signals were digitized at 250 Hz and time-locked video-EEG collected
continuously for 3–4 weeks.
Continuous 24-h video-EEG of mice was manually screened for seizures and
EEG abnormalities. Conditional α2-Na/K ATPase knockout mice displayed LVA
on EEG, which consisted of abrupt voltage suppression of the normal EEG
background usually containing ~3 Hz breathing artifact followed by burst
suppression activity gradually returning to normal. Quantitatively, LVA events
were defined by EEG background with a >75% reduction in total power within 15 s,
lasting <10 min in duration. Defined periods of abnormal EEG were annotated and
time-locked video observed to determine a correlation between behavior and EEG
events. Behavior was scored in a blinded fashion; during an LVA event, the
behavior of all mice in that cohort was scored without knowing which mouse had
the EEG abnormality. Behavior in the following categories was noted: sleeping,
eating, normal ambulation, abnormal ambulation (ataxic gait), abnormal stationary
posture (rearing behavior), and paralysis (lying on stomach or side and unable to
right self). Once all behaviors were recorded for each EEG abnormality, the
reviewer used a random number generator to select one control mouse from the
mice not exhibiting an EEG abnormality and was unblinded to quantify the
behavior of mice exhibiting EEG abnormalities.
TRAP-Seq analyses. TRAP was performed on the cortex from three replicates of
control and conditional knockout mice at age P24 modified from protocols as
described61. Briefly, the bilateral cortices from each mouse was dissected out
and, separately for each mouse, homogenized in 2 mL homogenization buffer
(20 mM Hepes-KOH, 150 mM Kcl, and 10 mM Mgcl2) with RNase inhibitor,
and 10% NP40 and 300 mM DHPC (Avanti Polar Lipids) was added to the
supernatant. After spinning down, 10% of the supernatant was used as for the
input fraction with the rest being subjected to immunoprecipitation (IP). GFP-
ribosome positive ribosomes were pulled down by incubation with affinity
antibody matrix (19C8 and 19F7, Memorial Sloan-Kettering Monoclonal anti-
body facility) at 4 °C overnight. RNA was collected by Qiagen miRNA kit. RNA
quality and concentration were assessed using high sensitivity RNA ChiP on the
Agilent BioAnalyzer. Intact RNA (RIN > 8, ~100 ng per sample) was used for the
library using NEBNext UltraRNA library preparation kit (E7530) as
described62,63. RNA was purified by oligdT beads and cDNA was synthesized by
reverse transcriptase. After DNA fragmentation, end repair, adaptor ligation and
PCR amplification, and libraries were used for Illumina deep sequencing.
Sequencing of the RNA was performed as described above. Sequencing was
performed on 12 samples: input from each cortical samples of three control
mice, IP from cortical samples of three control mice, input from cortical samples
of three conditional knockout mice and IP from cortical samples of three con-
ditional knockout mice.
Targeted metabolomics (liquid chromatography–mass spectrometry). Meta-
bolites from powderized flash-frozen brain tissue were extracted in ice-cold 80%
methanol. Subsequently, extract from the equivalent of 1 mg tissue was dried down
in a room temperature speed-vac for metabolomics analysis. Metabolites were
resolved using reverse phase ion-paired chromatography on an Agilent 1290
Infinity II Series LC and detected by MRM in negative ion mode on an Agilent
6470 series triple quadrupole mass spectrometer. The liquid
chromatography–tandem mass spectrometry (LC–MS/MS) targeted MRM method
used for metabolomics analysis was developed and implemented by Agilent
Technologies.
High-performance liquid chromatography. Flash-frozen brain tissue was dis-
sociated in 50 µL perchloric acid per mg of tissue (wet) and flash frozen. Deriva-
tization, detection, and quantification of D-serine and L-serine were then
performed as described64. Briefly, 2.5 µL of sample were derivatized in 2.5 µL of
aqueous phase with an excess (5 µL) of OPA/MAC mix (0.02 g o-Phthaldialdehyde
in 1 mL methanol+ 0.01g N-acetyl-L-cysteine+ 9 mL OPA diluent) for 2 min,
followed by treatment with 2 µL of 1M acetic acid. Chiral separation of amino
acids in the derivatized samples was achieved via HPLC on a modular Shimadzu
system (C10 Accucore column, 150 × 2.1 mm, 2.6 µm pores) at 40 °C, at a flow rate
0.2 mL/min using a non-isocratic method (0–6 min 3% organic, 6–10 min 20%
organic, 10–14 min 80% organic). Injection volume was 1 µL. The organic phase
consisted of 100% methanol and the aqueous phase of 50 mM phosphate buffer
(pH= 4.34). For quantification, standards of D-serine and L-serine were prepared
in aqueous mobile phase and treated similarly to the samples. The area under the
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D-serine and L-serine peaks was resolved using LabSolution software to obtain D-
and L-serine concentration in the samples relative to their respective standards.
Gas chromatography–mass spectrometry. Mice were perfused with 25 mL cold
heparinized PBS and tissues flash frozen. Metabolites were extracted from tissue
homogenized in 10 µL/mg wet weight of 65% EtOH by sonicating for 30 s at 50%
amplitude, spun 10 min at 6000 × g. Supernatants were pooled, labeled standards
were added, and then the solution was lyophilized using a speed-vac. Derivatization
was carried out by adding 75 ul MSTFA (N-methyl-N trimethylsilyltri-
fluoroacetamide)/CH3CN(1:3) and heating for 30 min at 70 °C.
Derivatized samples were analyzed on an Agilent 7890A gas chromatograph
interfaced to an Agilent 5975C mass spectrometer. The GC column used for the
study was a HP-5MS (30 m, 0.25 mm i.d., 0.25 µm film coating P.J. Cobert St.
Louis, MO). A linear temperature gradient was used. The initial temperature of 80°
was held for 2 min and increased to 300 at 10°/min. The temperature was held at
300 °C for 6 min. The samples were run by electron ionization and the source
temperature, electron energy and emission current were 250 °C, 70 eV, and 300 µA,
respectively. The injector and transfer line temperatures were 250 °C.
Glycine quantitation was carried out by monitoring the ions at m/z 276 for
glycine and 278 for glycine-d2. Serine quantitation was carried out by monitoring
the ions at m/z 306 for serine and 309 for serine-d3.
Transmission electron microscopy. P24 mice were pericardially perfused for 2
min with 37C Ringer’s solution followed by 5 min with 37C TEM fixative (0.15 M
cacodylatte buffer Ted Pella pH 7.4 containing 2.5% glutaraldehyde-EMS and 2%
paraformaldehyde-EMS with 2 mM calcium chloride), then tissue fixed at least
overnight in 4 °C TEM fixative. Sections were made with a Leica EM UC7 Ultra-
microtome. Images were taken from L2/3 of motor cortex using a JEOL JEM-1400
120 kV TEM. Astrocytes were recognized morphologically focusing on perivascular
astrocytes for ease of morphological identification. Abnormal vs. normal astrocytic
mitochondria were judged by an experienced, blinded observer (see Supplementary
Fig. 11a for examples) using the criteria as follows. Astrocytes were identified at low
magnification (3000×) based on their classic EM morphology (nucleus and cyto-
plasm), and presence of bundles of cytoplasmic cytoskeletal intermediate filaments.
They were then observed at higher magnification (8000×). Both cross sectioned and
longitudinally sectioned mitochondria were studied. Identification of abnormal
mitochondria were based on the following criteria—overall morphology, intactness
of the mitochondrial double layer membrane, distortions or abnormal swellings of
mitochondria cristae, localized changes in mitochondrial matrix, such as vacuoli-
zation, compaction of membranes and extreme density. Mitochondrial morphology
in the neighboring neuropil (blood vessels, dendrites, axons, axonal terminals, etc.)
was compared as reference.
Serine- and glycine-free diet. Modified diets were purchased from LabDiet. Four
modified diets were used: Ctrl (5BQS) and serine- and glycine-free diet (5BQT) as
previously described65, and serine-free (5WNT) and glycine-free (5WNU). The
serine- and glycine-free and Ctrl diets are the same except that all serine and
glycine is replaced by other amino acids in the same ratios such that the total
protein percentage is comparable. Serine-free and glycine-free are the same as
serine- and glycine-free, except that serine-free has glycine added back in and
glycine-free has serine added back in, again, with same percentage total protein.
Animals were weaned directly onto the modified diets at 17 days of age and stayed
on the modified diet for their entire life. All animals were given free access to water.
A subset of animals was weighed daily starting at 17 days of age, and/or began
behavioral testing at 30 days of age, including daily constant velocity rotarod
testing and every other day paralysis monitoring. These experiments continued for
the lifespan of the mice. All experiments, including weights, paralysis monitoring,
and rotarod, were conducted with the experimenter blinded to the diet and the
genotype of the mice. For studies on the effect of the reversal of the diet, mice were
treated as above with one exception: one cohort of mice was switched from the
serine- and glycine-free diet to the control diet at P40.
Statistical analysis. Statistical analyses were done using GraphPad Prism soft-
ware. Bar graphs are presented as the mean ± s.e.m. For experiments in which only
two groups were analyzed, the two-tailed unpaired t test was used. No statistical
methods were used to predetermine sample sizes, but our sample sizes are similar
to those generally employed in the field. Data distribution was assumed to be
normal, but this was not formally tested. Details on statistical results including
exact P values are provided in the Supplementary statistics data file (Supplementary
Data 2) or in the figure legend if space allows.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All sequencing data is deposited into GEO with accession code GSE145012. Differentially
expressed genes and metabolomics source data are provided in Supplementary Data 1.
Statistical details for all statistical tests including exact P values included in
Supplementary Data 2. All data supporting our findings can be found within the article
and its Supplementary Information. Source data are provided with this paper.
Code availability
Custom code used for intrinsic optical signal (iOS) imaging, wide-field calcium imaging
and EEG acquisition, processing, and analysis is provided on github (https://github.com/
brierl/Nature_Comm_CSD).
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